Ozonoterapiya zatyanuvshikhsya pnevmoniy

Igor' Ivanovich Belyanin , E I Shmelev

Russian Medicine ›› 2010, Vol. 16 ›› Issue (1) : 6 -11.

PDF
Russian Medicine ›› 2010, Vol. 16 ›› Issue (1) : 6 -11. DOI: 10.17816/rmj37778
Articles
other

Ozonoterapiya zatyanuvshikhsya pnevmoniy

Author information +
History +
PDF

Abstract

After 3 weeks of treatment, 36 patients who were found to have X-ray signs of pneumonia (pulmonary infiltrative changes, fever, productive cough, weakness) were randomized into two equal groups (a study group and a control one). Antibacterial therapy was changed and continued by 77.7 and 55% of control and study group patients, respectively. The study group patients were additionally given intravenous infusions of 400 ml of ozonized sodium chloride solution (pO3) containing 1.6 мg/ ml of O3 twice weakly for 21 days. Blood ozonization considerably accelerated the resolution time of X-ray infiltrative changes so that they were undetectable in all the study group patients by week 4 while they were only in 61.1% of the control groups. Blood ozonization used in combination with antibiotics permitted achievement of a sputum negative reaction against Chlamydia and Mycoplasma 2-3 weeks earlier. Infusions of pO3 just after the first ozonization made it possible to eliminate a clinical sign of chronic infection, such as weakness, to accelerate productive cough relief by 10 days, and to halve the number of fever patients at week 2, as compared with the controls. Ozone therapy for protracted pneumonias substantially enhances the efficiency of antibiotic treatment.

Keywords

pneumonia / intravenous dissolved ozone infusion / antibiotic therapy

Cite this article

Download citation ▾
Igor' Ivanovich Belyanin, E I Shmelev. Ozonoterapiya zatyanuvshikhsya pnevmoniy. Russian Medicine, 2010, 16(1): 6-11 DOI:10.17816/rmj37778

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Дворецкий Л. И., Данилина В. А. // Инфекции и антимикроб. тер. - 2004. - Т. 6, № 4. - С. 126-133.

[2]

Новиков Ю. К. // Рус. мед. журн. Болезни дыхательных путей. - 2004. - Т. 12, № 21. - С. 1226-1231.

[3]

Ноников В. Е. // Рус. мед. журн. - 2004. - Т. 12, № 21. - С. 1193-1197.

[4]

Перетягин С. П. // Озон в биологии и медицине. - Н. Новгород, 1992. - С. 4-5.

[5]

Разумовский С. Д. // Озон в биологии и медицине. - Н. Новгород, 1995. - С. 4.

[6]

Blanchard J. S. // Ann. Rev. Biochem. - 1996. - Vol. 65. - P. 215-391.

[7]

Bocci U., Paulesu L. // Haematologica. - 1990. - Vol. 75. - P. 510-515.

[8]

Hocher M. H., Cazzard B. S. // AIDS. - 1991. - Vol. 5, N 8. - Р. 981-984.

[9]

Hotchkiss J. A., Harkema J. R. // Toxicol. Appl. Pharmacol. - 1992. - Vol. 114, N 2. - P. 182-187.

[10]

Ozmen V., Thomes V. O., Healy J. T. // Am. Surg. - 1993. - Vol. 59, N 5. - P. 297-303.

[11]

Paulesu L., Luzzi E., Bocci V. // Lymphokine Cytokine Res. - 1991. - Vol. 10. - P. 409-412.

[12]

Richermi P., Franchini M., Valdenassi L. Ossigeno-ozono terapia. - Pavia-Bergamo, 1995.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

143

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/